A botulinus toxin neutralizer comprises at least one fatty acid having at least 12 carbon atoms. Such a fatty acid may be a saturated fatty acid such as lauric acid, myristic acid, palmitic acid, stearic acid, nonadecanoic acid, arachidic acid or behenic acid, or an unsaturated fatty acid such as oleic acid. The toxin neutralizer acts as if it were an antagonistic receptor for botulinus toxin and, when encountering botulinus toxin in the human body, it combines directly with the toxin and prevents the toxin from combining with the neuromuscular tissues of the human body. Hence the neutralizer prevents the outbreak of botulism. The toxin thus neutralized and affixed to the botulinus toxin is excreted from the human body. The botulinus toxin neutralizer can be manufactured easily and economically from a naturally occurring glyceride and is thus far less costly than the known antitoxin of ganglioside GTlb produced from bovine brain.